Local News

Curbing Inflammation Could Reduce Heart Disease Risk Linked to Blood Disorder

By November 15, 2019No Comments

More than 1 in 10 adults over the age of 70 have a blood disorder called clonal hematopoiesis of indeterminate potential, or CHIP, in which some blood stem cells become too abundant because of acquired cancer-predisposing mutations. CHIP can lead to cancer, but the biggest health risk from the disorder may be a heart attack or stroke.

Researchers from the Broad Institute of MIT and Harvard and Massachusetts General Hospital (MGH) have found that a common variant in the gene for an inflammatory molecule reduces that risk, suggesting that therapeutically blocking inflammation could help prevent cardiovascular disease in some patients with CHIP.

“In the clinic, we now use a fairly standard cocktail of medicines such as statins and aspirin to prevent cardiovascular events, and those can be beneficial for people with CHIP,” said Pradeep Natarajan, associate member at the Broad Institute, director of preventive cardiology at MGH, and assistant professor of medicine at Harvard Medical School. “Here we’ve defined a subset of individuals who may one day benefit even more from an additional completely different therapy.”